A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

NCT00637494 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

292

Enrollment

INDUSTRY

Sponsor class

Stopped DRC recommended stopping study as it had missed its primary endpoint

Conditions

Psychotic Depression
Severe Major Depression With Psychotic Features
Psychosis

Interventions

DRUG: mifepristone
DRUG: placebo

Sponsor

Corcept Therapeutics